![sas jmp clinical sas jmp clinical](https://slidetodoc.com/presentation_image_h/ce3a13354ad54ac448f7fa662e6a9541/image-24.jpg)
![sas jmp clinical sas jmp clinical](https://www.jmp.com/en_ca/software/clinical-data-analysis-software/_jcr_content/par/styledcontainer_fadb/par/lightbox_68f6/lightboxThumbnail.img.png)
Sas jmp clinical software#
Quickly evaluate efficacy and safety, and identify potentially harmful symptoms, including liver toxicity.ĭig deep into clinical trial events, findings and interventions using sophisticated statistical algorithms.What first began as an agricultural research project at North Carolina State University eventually grew into a full-fledged software and services company by 1976. Track patient exposure to treatment, identify drug interactions, and analyze distributions, event rates and risk.ĭetermine the onset of an adverse event and its outcomes, and discern event patterns across treatment groups. Identify diseases or complexes that may arise due to ongoing treatments using standardized or customized medical queries. Save time and effort in assembling the components for these required reports through the automated generation of relevant tables and listings in. Quickly identify efficacy signals in solid tumor clinical trials using visualizations tailored to RECIST criteria, including survival plots, swimmer plots, waterfall plots and spider plots.
Sas jmp clinical verification#
Reduce costly on-site source data verification while preserving data integrity and the safety of study participants. Visually identify modifications to data and isolate data entry and EDC errors for downstream users of the data. Reveal trends and outliers and accelerate discovery via interactive visualization and sophisticated pattern detection.Īssess trial data for safety issues with the click of a button and create interactive reports of adverse events.ĭiscover data anomalies at the site and patient level, whether due to fraud, data quality or protocol errors. Instantly generate customizable patient profiles and easily communicate findings among review groups. Automatically compose a configurable patient narrative for each subject who experienced an adverse event (AE), including reporting for deaths, serious AEs, AEs of special interest and AEs resulting in study discontinuation.